TScan Therapeutics Announces Exercise of Underwriters'

WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...

Related Keywords

United States ,New York ,Heather Savelle ,Maghan Meyers ,Hc Wainwright Co ,Nasdaq ,Morgan Stanley ,Tscan Therapeutics Inc ,Exchange Commission ,Prospectus Department ,Td Securities United States ,Needham Company ,Morgan Stanley Co ,Globe Newswire Tscan Therapeutics Inc ,Sci Capital ,Nasdaq Tcrx ,Tscan Therapeutics ,Nc ,